Ewellness Healthcare (EWLL) Return on Equity ROE from the first quarter 2022 to first quarter 2021 and annually, average high and low, overall ranking from Mar 31 2022 to Mar 31 2021 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Ewellness Healthcare Corporation  (EWLL)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare

Ewellness Healthcare's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Ewellness Healthcare in the first quarter 2022?
Due to the lack of equity, it was not possible to calculate Ewellness Healthcare Corporation's return on equity (ROE) in its first quarter 2022

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter
Y / Y Equity Change - - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -4 0 -6 -1 -4
Return On Equity (TTM) - - - - -
EWLL's Total Ranking # # # # #
Equity (TTM) in Millions -6 -4 -6 -4 -5
Seq. Equity Change - - - - -
Seq. Net Income Change - - - - -

Back to EWLL Management Effectiveness >> EWLL's 5 Years Annual ROE >> Compare EWLL ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





EWLL Annual Return On Equity (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017
Total Equity in Millions -4 -7 -7 -4 -4
Y / Y Equity Change - - - - -
Net Income in Millions 0 -9 -9 -4 -1
Y / Y Net Income Change - - - - -
Return On Equity - - - - -

Back to EWLL Management Effectiveness >> EWLL's 5 Years Annual ROE >> Compare EWLL ROE to its Competitors




More Return On Equity Ratios
Healthcare Facilities Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
EWLL's' Return on Equity at Yahoo Finance
EWLL's Roe Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for EWLL's Competitors
Subscribers only: Roe for Ewellness Healthcare's Suppliers
Subscribers only: Return On Equity for EWLL's Customers




Companies with similar Return On Equity at Mar 31 2022, within Healthcare Sector ROE
Halozyme Therapeutics Inc   202.61 %
Cartesian Therapeutics Inc   200.16 %
Warby Parker Inc   193.86 %
Procept Biorobotics Corporation  170.48 %
Avid Bioservices Inc   156.25 %
Entrada Therapeutics Inc   143.64 %
Moderna Inc   121.86 %
Molecular Templates Inc   110.16 %
Idexx Laboratories Inc  103.69 %
REST EZ Inc.  99.51 %
Vyne Therapeutics Inc   96.49 %
Vir Biotechnology Inc   96.39 %
Ironwood Pharmaceuticals inc   95.21 %
Amgen Inc   95.07 %
Davita Inc   94.90 %
Maravai Lifesciences Holdings Inc   92.72 %
Vicarious Surgical Inc  91.60 %
Journey Medical Corp  89.42 %
Tenet Healthcare Corp  88.75 %
Abbvie Inc   86.23 %
Tivity Health Inc   81.80 %
Sensus Healthcare Inc   77.94 %
Biomx Inc  75.95 %
Eli Lilly And Company  73.77 %
Glucotrack Inc   73.46 %
Dynavax Technologies Corporation  65.79 %
Iteos Therapeutics Inc   64.68 %
Vivos Therapeutics Inc   63.60 %
Innoviva Inc   60.50 %
Uniqure N v   54.85 %

Date modified: 2026-09-08T15:10:38+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.